» Articles » PMID: 35299710

Low Diagnostic Yield and Time to Diagnostic Confirmation Results in Prolonged Use of Antimicrobials in Critically Ill Children

Abstract

Broad-spectrum antimicrobial therapy is a key driver of antimicrobial resistance. Here, we aimed to review indications for antimicrobial therapy, determine the proportion of suspected bacterial infections that are confirmed by culture, and assess the time taken for microbiology test results to become available in the paediatric intensive care unit (PICU). : A single-centre prospective observational cohort study of 100 consecutive general PICU admissions from 30 October 2019 to 19 February 2020. Data were collected from the hospital medical record and entered into a study database prior to statistical analysis using standard methods. : Of all episodes of suspected infection, 22% of lower respiratory tract infection, 43% of bloodstream and 0% of central nervous system infection were associated with growth on microbiology culture. 90% of children received antimicrobial therapy. Hospital-acquired infection occurred less commonly than primary infection, but an organism was grown in a greater proportion (64%) of cultures. Final laboratory reports for negative cultures were issued at a median of 120.3 hours for blood cultures and 55.5 hours for endotracheal tube aspirate cultures. : Despite most critically children receiving antimicrobial therapy, infection was often not microbiologically confirmed. Novel molecular diagnostics may improve rationalisation of treatment in this population.

Citing Articles

Enhanced diagnosis of severe bacterial and fungal respiratory infection in children using a rapid syndromic array-case report.

Clark J, Gouliouris T, Morris A, Curran M, White D, Daubney E Transl Pediatr. 2024; 13(4):697-703.

PMID: 38715674 PMC: 11071030. DOI: 10.21037/tp-23-525.


Rapid Detection of Antimicrobial Resistance Genes in Critically Ill Children Using a Custom TaqMan Array Card.

Clark J, Curran M, Gouliouris T, Morris A, Bousfield R, Navapurkar V Antibiotics (Basel). 2023; 12(12).

PMID: 38136735 PMC: 10740637. DOI: 10.3390/antibiotics12121701.


A qualitative investigation of paediatric intensive care staff attitudes towards the diagnosis of lower respiratory tract infection in the molecular diagnostics era.

Clark J, Morris A, Kanaris C, Inwald D, Butt W, Osowicki J Intensive Care Med Paediatr Neonatal. 2023; 1(1):10.

PMID: 37425493 PMC: 10329081. DOI: 10.1007/s44253-023-00008-z.


The rapid detection of respiratory pathogens in critically ill children.

Clark J, Morris A, Curran M, White D, Daubney E, Kean I Crit Care. 2023; 27(1):11.

PMID: 36627688 PMC: 9831374. DOI: 10.1186/s13054-023-04303-1.


Rapid Assay for Sick Children with Acute Lung infection Study (RASCALS): diagnostic cohort study protocol.

Clark J, Kean I, Curran M, Khokhar F, White D, Daubney E BMJ Open. 2021; 11(11):e056197.

PMID: 34845080 PMC: 8634010. DOI: 10.1136/bmjopen-2021-056197.

References
1.
Da Silva P, de Aguiar V, Brunow de Carvalho W, Fonseca M . Value of clinical pulmonary infection score in critically ill children as a surrogate for diagnosis of ventilator-associated pneumonia. J Crit Care. 2014; 29(4):545-50. DOI: 10.1016/j.jcrc.2014.01.010. View

2.
Straney L, Clements A, Parslow R, Pearson G, Shann F, Alexander J . Paediatric index of mortality 3: an updated model for predicting mortality in pediatric intensive care*. Pediatr Crit Care Med. 2013; 14(7):673-81. DOI: 10.1097/PCC.0b013e31829760cf. View

3.
Akinkugbe O, Cooke F, Pathan N . Healthcare-associated bacterial infections in the paediatric ICU. JAC Antimicrob Resist. 2021; 2(3):dlaa066. PMC: 8210264. DOI: 10.1093/jacamr/dlaa066. View

4.
Stocker M, Ferrao E, Banya W, Cheong J, MacRae D, Furck A . Antibiotic surveillance on a paediatric intensive care unit: easy attainable strategy at low costs and resources. BMC Pediatr. 2012; 12:196. PMC: 3534515. DOI: 10.1186/1471-2431-12-196. View

5.
Telles J, Richard N, Gillet Y, Hartwig S, Pouzol S, Dollet S . Viral and bacterial pathogens identification in children hospitalised for severe pneumonia and parapneumonic empyema. Pneumonia (Nathan). 2019; 1:11-19. PMC: 6707413. DOI: 10.15172/pneu.2012.1/228. View